{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:13:39Z","timestamp":1761974019500,"version":"build-2065373602"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,5,18]],"date-time":"2013-05-18T00:00:00Z","timestamp":1368835200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00213-013-3143-4","type":"journal-article","created":{"date-parts":[[2013,5,17]],"date-time":"2013-05-17T07:58:08Z","timestamp":1368777488000},"page":"113-123","source":"Crossref","is-referenced-by-count":3,"title":["Insights into functional pharmacology of \u03b11 GABAA receptors: how much does partial activation at the benzodiazepine site matter?"],"prefix":"10.1007","volume":"230","author":[{"given":"Sr\u0111an","family":"Joksimovi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zdravko","family":"Varagic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jovana","family":"Kova\u010devi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Van Linn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija","family":"Mili\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sundari","family":"Rallapalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Timi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Sieghart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miroslav M.","family":"Savi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,18]]},"reference":[{"key":"3143_CR1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.105.089920","volume":"316","author":"JR Atack","year":"2006","unstructured":"Atack JR, Wafford KA, Tye SJ, Cook SM, Sohal B, Pike A et al (2006) TPA023 (7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl )-1,2,4-triazolo(4,3-b)pyridazine), an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates. J Pharmacol Exp Ther 316:410\u2013422","journal-title":"J Pharmacol Exp Ther"},{"key":"3143_CR2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/0269881109354927","volume":"25","author":"JR Atack","year":"2011","unstructured":"Atack JR, Wafford KA, Street LJ, Dawson GR, Tye S, Van Laere K et al (2011) MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans. J Psychopharmacol 25:314\u2013328","journal-title":"J Psychopharmacol"},{"key":"3143_CR3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00008877-200004000-00004","volume":"11","author":"C Belzung","year":"2000","unstructured":"Belzung C, Le Guisquet AM, Griebel G (2000) Beta-CCT, a selective BZ-omega1 receptor antagonist, blocks the anti-anxiety but not the amnesic action of chlordiazepoxide in mice. Behav Pharmacol 11:125\u2013131","journal-title":"Behav Pharmacol"},{"key":"3143_CR4","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.2174\/138161207782341330","volume":"13","author":"B Birnir","year":"2007","unstructured":"Birnir B, Korpi ER (2007) The impact of sub-cellular location and intracellular neuronal proteins on properties of GABA(A) receptors. Curr Pharm Des 13:3169\u20133177","journal-title":"Curr Pharm Des"},{"key":"3143_CR5","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1523\/JNEUROSCI.16-17-05415.1996","volume":"16","author":"Y Chang","year":"1996","unstructured":"Chang Y, Wang R, Barot S, Weiss DS (1996) Stoichiometry of a recombinant GABAA receptor. J Neurosci 16:5415\u20135424","journal-title":"J Neurosci"},{"key":"3143_CR6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1124\/mol.59.3.442","volume":"59","author":"F Crestani","year":"2001","unstructured":"Crestani F, L\u00f6w K, Keist R, Mandelli M, M\u00f6hler H, Rudolph U (2001) Molecular targets for the myorelaxant action of diazepam. Mol Pharmacol 59:442\u2013445","journal-title":"Mol Pharmacol"},{"key":"3143_CR7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1017\/S1092852900009871","volume":"10","author":"GR Dawson","year":"2005","unstructured":"Dawson GR, Collinson N, Atack JR (2005) Development of subtype selective GABAA modulators. CNS Spectr 10:21\u201327","journal-title":"CNS Spectr"},{"key":"3143_CR8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/schbul\/sbs073","volume":"38","author":"HC Fibiger","year":"2012","unstructured":"Fibiger HC (2012) Psychiatry, the pharmaceutical industry, and the road to better therapeutics. Schizophr Bull 38:649\u2013650","journal-title":"Schizophr Bull"},{"key":"3143_CR9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00180822","volume":"88","author":"H Friedman","year":"1986","unstructured":"Friedman H, Abernethy DR, Greenblatt DJ, Shader RI (1986) The pharmacokinetics of diazepam and desmethyldiazepam in rat brain and plasma. Psychopharmacology 88:267\u2013270","journal-title":"Psychopharmacology"},{"key":"3143_CR10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s002130051108","volume":"146","author":"G Griebel","year":"1999","unstructured":"Griebel G, Perrault G, Letang V, Granger P, Avenet P, Schoemaker H et al (1999) New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes. Psychopharmacology 146:205\u2013213","journal-title":"Psychopharmacology"},{"key":"3143_CR11","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0026-895X(25)13351-8","volume":"44","author":"KL Hadingham","year":"1993","unstructured":"Hadingham KL, Wingrove PB, Wafford KA, Bain C, Kemp JA, Palmer KJ et al (1993) Role of the beta subunit in determining the pharmacology of human gamma-aminobutyric acid type A receptors. Mol Pharmacol 44:1211\u20131218","journal-title":"Mol Pharmacol"},{"key":"3143_CR12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fendo.2012.00010","volume":"3","author":"CM Helms","year":"2012","unstructured":"Helms CM, Rossi DJ, Grant KA (2012) Neurosteroid influences on sensitivity to ethanol. Frontiers in Endocrinology 3:10","journal-title":"Frontiers in Endocrinology"},{"key":"3143_CR13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0022-3565(25)21965-6","volume":"229","author":"T Hironaka","year":"1984","unstructured":"Hironaka T, Fuchino K, Fujii T (1984) Absorption of diazepam and its transfer through the blood\u2013brain barrier after intraperitoneal administration in the rat. J Pharmacol Exp Ther 229:809\u2013815","journal-title":"J Pharmacol Exp Ther"},{"key":"3143_CR14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0091-3057(95)02126-4","volume":"54","author":"S Hogg","year":"1996","unstructured":"Hogg S (1996) A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 54:21\u201330","journal-title":"Pharmacol Biochem Behav"},{"key":"3143_CR15","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.euroneuro.2012.05.003","volume":"23","author":"S Joksimovi\u0107","year":"2013","unstructured":"Joksimovi\u0107 S, Divljakovi\u0107 J, Van Linn ML, Varagic Z, Brajkovi\u0107 G, Milinkovi\u0107 MM et al (2013) Benzodiazepine-induced spatial learning deficits in rats are regulated by the degree of modulation of \u03b1(1) GABA(A) receptors. Eur Neuropsychopharmacol 23:390\u2013399","journal-title":"Eur Neuropsychopharmacol"},{"key":"3143_CR16","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/j.1460-9568.2010.07473.x","volume":"32","author":"Y Kasugai","year":"2010","unstructured":"Kasugai Y, Swinny JD, Roberts JD, Dalezios Y, Fukazawa Y, Sieghart W et al (2010) Quantitative localisation of synaptic and extrasynaptic GABAA receptor subunits on hippocampal pyramidal cells by freeze-fracture replica immunolabelling. Eur J Neurosci 32:1868\u20131888","journal-title":"Eur J Neurosci"},{"key":"3143_CR17","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00213-008-1401-7","volume":"203","author":"SC Licata","year":"2009","unstructured":"Licata SC, Platt DM, Cook JM, Van Linn ML, Rowlett JK (2009) Contribution of alpha1 subunit-containing gamma-aminobutyric acidA (GABAA) receptors to motor-impairing effects of benzodiazepines in squirrel monkeys. Psychopharmacology 203:539\u2013546","journal-title":"Psychopharmacology"},{"key":"3143_CR18","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.1073\/pnas.0502579102","volume":"102","author":"A Lippa","year":"2005","unstructured":"Lippa A, Czobor P, Stark J, Beer B, Kostakis E, Gravielle M et al (2005) Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator. Proc Natl Acad Sci USA 102:7380\u20137385","journal-title":"Proc Natl Acad Sci USA"},{"key":"3143_CR19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/75761","volume":"3","author":"RM McKernan","year":"2000","unstructured":"McKernan RM, Rosahl TW, Reynolds DS, Sur C, Wafford KA, Atack JR et al (2000) Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat Neurosci 3:587\u2013592","journal-title":"Nat Neurosci"},{"key":"3143_CR20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/FBP.0b013e3283512c85","volume":"23","author":"M Mili\u0107","year":"2012","unstructured":"Mili\u0107 M, Divljakovi\u0107 J, Rallapalli S, van Linn ML, Timi\u0107 T, Cook JM, Savi\u0107 MM (2012) The role of \u03b11 and \u03b15 subunit-containing GABAA receptors in motor impairment induced by benzodiazepines in rats. Behav Pharmacol 23:191\u2013197","journal-title":"Behav Pharmacol"},{"key":"3143_CR21","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1111\/j.1460-9568.2006.04775.x","volume":"23","author":"HV Morris","year":"2006","unstructured":"Morris HV, Dawson GR, Reynolds DS, Atack JR, Stephens DN (2006) Both alpha2 and alpha3 GABAA receptor subtypes mediate the anxiolytic properties of benzodiazepine site ligands in the conditioned emotional response paradigm. Eur J Neurosci 23:2495\u20132504","journal-title":"Eur J Neurosci"},{"key":"3143_CR22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.108.00505","volume":"60","author":"RW Olsen","year":"2008","unstructured":"Olsen RW, Sieghart W (2008) International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol Rev 60:243\u2013260","journal-title":"Pharmacol Rev"},{"key":"3143_CR23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00213-002-1189-9","volume":"164","author":"DM Platt","year":"2002","unstructured":"Platt DM, Rowlett JK, Spealman RD, Cook J, Ma C (2002) Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA\/alpha1-preferring antagonist beta-CCt in squirrel monkeys. Psychopharmacology 164:151\u2013159","journal-title":"Psychopharmacology"},{"key":"3143_CR24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejphar.2010.03.015","volume":"636","author":"J Ramerstorfer","year":"2010","unstructured":"Ramerstorfer J, Furtm\u00fcller R, Vogel E, Huck S, Sieghart W (2010) The point mutation gamma 2F77I changes the potency and efficacy of benzodiazepine site ligands in different GABAA receptor subtypes. Eur J Pharmacol 636:18\u201327","journal-title":"Eur J Pharmacol"},{"key":"3143_CR25","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1021\/jm801652d","volume":"52","author":"FM Rivas","year":"2009","unstructured":"Rivas FM, Stables JP, Murphree L, Edwankar RV, Edwankar CR, Huang S et al (2009) Antiseizure activity of novel gamma-aminobutyric acid (A) receptor subtype-selective benzodiazepine analogues in mice and rat models. J Med Chem 52:1795\u20131798","journal-title":"J Med Chem"},{"key":"3143_CR26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1017\/S1092852900009895","volume":"10","author":"JK Rowlett","year":"2005","unstructured":"Rowlett JK, Cook JM, Duke AN, Platt DM (2005) Selective antagonism of GABAA receptor subtypes: an in vivo approach to exploring the therapeutic and side effects of benzodiazepine-type drugs. CNS Spectr 10:40\u201348","journal-title":"CNS Spectr"},{"key":"3143_CR27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrd3502","volume":"10","author":"U Rudolph","year":"2011","unstructured":"Rudolph U, Knoflach F (2011) Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes. Nat Rev Drug Discov 10:685\u2013697","journal-title":"Nat Rev Drug Discov"},{"key":"3143_CR28","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev.pharmtox.44.101802.121429","volume":"44","author":"U Rudolph","year":"2004","unstructured":"Rudolph U, M\u00f6hler H (2004) Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annu Rev Pharmacol Toxicol 44:475\u2013498","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3143_CR29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pbb.2004.07.013","volume":"79","author":"MM Savi\u0107","year":"2004","unstructured":"Savi\u0107 MM, Obradovi\u0107 DI, Ugre\u0161i\u0107 ND, Cook JM, Yin W, Bokonji\u0107 DR (2004) Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt. Pharmacol Biochem Behav 79:279\u2013290","journal-title":"Pharmacol Biochem Behav"},{"key":"3143_CR30","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1017\/S1461145709000108","volume":"12","author":"MM Savi\u0107","year":"2009","unstructured":"Savi\u0107 MM, Milinkovi\u0107 MM, Rallapalli S, Clayton T Sr, Joksimovi\u0107 S, Van Linn M, Cook JM (2009) The differential role of alpha1- and alpha5-containing GABA(A) receptors in mediating diazepam effects on spontaneous locomotor activity and water-maze learning and memory in rats. Int J Neuropsychopharmacol 12:1179\u20131193","journal-title":"Int J Neuropsychopharmacol"},{"key":"3143_CR31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/1568015054863837","volume":"5","author":"W Sieghart","year":"2005","unstructured":"Sieghart W, Ernst M (2005) Heterogeneity of GABAA receptors: revived interest in the development of subtype-selective drugs. Curr Med Chem Cent Nerv Syst Agents 5:217\u2013242","journal-title":"Curr Med Chem Cent Nerv Syst Agents"},{"key":"3143_CR32","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.tips.2012.08.003","volume":"33","author":"P Skolnick","year":"2012","unstructured":"Skolnick P (2012) Anxioselective anxiolytics: on a quest for the Holy Grail. Trends Pharmacol Sci 33:611\u2013620","journal-title":"Trends Pharmacol Sci"},{"key":"3143_CR33","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.neuropharm.2012.03.001","volume":"63","author":"KS Smith","year":"2012","unstructured":"Smith KS, Engin E, Meloni EG, Rudolph U (2012) Benzodiazepine-induced anxiolysis and reduction of conditioned fear are mediated by distinct GABAA receptor subtypes in mice. Neuropharmacology 63:250\u2013258","journal-title":"Neuropharmacology"},{"key":"3143_CR34","doi-asserted-by":"crossref","first-page":"7548","DOI":"10.1016\/j.bmc.2010.08.049","volume":"18","author":"W Yin","year":"2010","unstructured":"Yin W, Majumder S, Clayton T, Petrou S, Van Linn ML, Namjoshi OA et al (2010) Design, synthesis, and subtype selectivity of 3,6-disubstituted \u03b2-carbolines at Bz\/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse. Bioorg Med Chem 18:7548\u20137564","journal-title":"Bioorg Med Chem"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-013-3143-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-013-3143-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-013-3143-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T10:28:13Z","timestamp":1746008893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-013-3143-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,18]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["3143"],"URL":"https:\/\/doi.org\/10.1007\/s00213-013-3143-4","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"type":"print","value":"0033-3158"},{"type":"electronic","value":"1432-2072"}],"subject":[],"published":{"date-parts":[[2013,5,18]]}}}